Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants

• Published in: Acta Paediatrica Vol. 90; no. 10; pp. 1171 - 1175
• Main Authors: Blennow, M, Sävman, K, Ilves, P, Thoresen, M, Rosengren, L
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.10.2001
• Subjects: Birth asphyxia; brain proteins; cerebrospinal fluid; glial fibrillary protein; neurofilament protein; neuron-specific enolase; protein S-100
• ISSN: 0803-5253; 1651-2227
• DOI: 10.1111/j.1651-2227.2001.tb03249.x

Upcoming trials of neuroprotective strategies in severely asphyxiated newborn infants emphasize the need for early and objective markers of both good and bad long‐term prognosis. Traditional markers such as neurological depression and seizures are not specific. Aim: To study whether measurement in the cerebrospinal fluid of some proteins known to be specific to the central nervous system was in covariance with the clinical course and long‐term prognosis. Methods: Twenty‐two asphyxiated infants were included in the study and compared with a control group of 8 infants without signs of perinatal asphyxia. Cerebrospinal fluid (CSF) was collected during the first 4 d of life and analysed for neurofilament protein (NFp), glial fibrillary acidic protein (GFAp), protein S‐100 and neuron‐specific enolase (NSE). Results: The concentrations of all four proteins were significantly increased in the CSF of asphyxiated infants. The concentrations correlated significantly with other indicators of long‐term prognosis and to neurological impairment at 1 y of age, or death before that time. Specifically, concentrations were excessively high in the five infants who died. Conclusions: High concentrations of brain‐specific proteins are released into the CSF of asphyxiated infants. It might therefore be useful to measure these concentrations when excluding patients with the gravest prognosis from neuroprotective trials.